Company Filing History:
3 out of 867 
1 out of 21 
1 out of 2,310 
Years Active: 2020-2022
Title: **Inventor Ryan Flynn: Pioneering Advances in Medical Treatments**
Introduction
Ryan Flynn, a notable inventor based in Minneapolis, MN, has made significant contributions to the field of medical innovations. With a total of four patents to his name, Flynn's work focuses primarily on innovative treatments and compositions that address critical health challenges.
Latest Patents
Flynn's latest patents showcase his inventive prowess. One such patent addresses the treatment of graft versus host disease (GVHD), a condition that can occur after stem cell or bone marrow transplantation. This invention involves using compounds that inhibit ROCK2, providing novel methods for treating both acute and chronic GVHD through specific formulas outlined in his patent documents.
Additionally, Flynn has developed polyglycerol compositions which specifically contain no more than about 5% by weight of monoglycerol in relation to the non-water ingredients. This innovation has a combined tetraglycerol and higher polyglycerol content of at least 55%. The methods for creating these compositions involve the use of crude glycerin comprising a particular percentage of glycerol-containing compounds.
Career Highlights
Throughout his career, Ryan Flynn has been associated with prominent companies in the industry, including Cargill Inc. and Kadmon Corporation, LLC. His experience in these companies has undoubtedly provided him with a strong foundation in research and development, allowing him to focus on groundbreaking inventions in the medical field.
Collaborations
Flynn has worked alongside esteemed colleagues such as Kevin Ray Anderson and Frank P Lochel. Together, they have collaborated on various projects, pushing the boundaries of innovation and contributing to advancements in treatments that could potentially improve patient outcomes.
Conclusion
Ryan Flynn's inventive contributions, particularly in the treatment of GVHD and the development of unique polyglycerol compositions, highlight his dedication to addressing complex medical challenges. His collaborations and experience with industry-leading companies continue to amplify his influence as an inventor, paving the way for future innovations in healthcare.